Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 8, 2019 Off

Teva Announces Launch of $1,500,000,000 Offering of Senior Notes

By BusinessWire

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: Teva…

November 8, 2019 Off

Biodesix Named Company of the Year by Colorado BioScience Association

By BusinessWire

Expanded Pipeline and Clinical Data Milestones Propel Company to Top Spot BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. has been named Company of…

November 8, 2019 Off

United States Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Insights, Trends and Forecasts, 2019-2021 & 2031 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)” report has been…

November 8, 2019 Off

Fresenius Kabi Introduces Heparin Sodium Injection, USP Simplist® Prefilled Syringe in 5,000 USP units per 0.5 mL presentation

By BusinessWire

Small-volume presentation now available exclusively in FDA-approved ready-to-administer prefilled syringe LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today the availability in…

November 8, 2019 Off

Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

By BusinessWire

Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presented positive…

November 8, 2019 Off

Mirum Pharmaceuticals Presents Data Demonstrating Long-term Durability of Treatment Effect of Maralixibat in Children With Cholestatic Liver Diseases

By BusinessWire

Statistically and clinically significant effects on pruritus, xanthomas and growth maintained for up to four years of treatment in Alagille…

November 8, 2019 Off

Gilead Announces New Data from Viral Hepatitis Research Programs at The Liver Meeting® 2019

By BusinessWire

— Data Demonstrate Reductions in Hepatocellular Carcinoma in Hepatitis B (HBV) Patients Treated with Vemlidy — — Improved Markers of…

November 8, 2019 Off

Axcella Presents Data at The Liver Meeting™ Providing New Mechanistic Insights on Observed Multifactorial Effects of its Liver Product Candidates

By BusinessWire

AXA1665 enhances amino acid metabolism and improves ammonia disposal in subjects with mild and moderate hepatic insufficiency AXA1125 impacts key…

November 8, 2019 Off

Cyclo Therapeutics Signs Agreement with Worldwide Clinical Trials to Conduct Pivotal Trial in Niemann-Pick Disease Type C

By BusinessWire

Pivotal trial will study the intravenous administration of the Company’s Trappsol® Cyclo™ drug and will focus on systemic and neurologic…

November 8, 2019 Off

Arrowhead and Collaborator Janssen Present Phase 2 Clinical Data for Investigational Hepatitis B Regimens at The Liver Meeting® 2019

By BusinessWire

PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly…

Posts pagination

Previous 1 … 5,353 5,354 5,355 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine